propranolol has been researched along with Angiosarcoma in 8 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this neoadjuvant window of opportunity study is to prospectively evaluate the activity of propranolol monotherapy in patients with cutaneous angiosarcoma." | 9.34 | PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study. ( Beijnen, JH; Haas, RL; Heinhuis, KM; Huitema, ADR; IJzerman, NS; Koenen, AM; Steeghs, N; van der Graaf, WTA; van Houdt, WJ, 2020) |
| " This study aimed to evaluate the clinical efficacy and adverse events (AEs) of anthracycline and propranolol combination in stage 3 HSA-affected dogs." | 5.91 | Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma. ( Fujii, Y; Goto, S; Iwasaki, R; Mori, T; Terauchi, M; Yoshikawa, R, 2023) |
| " The treatment agreed during the interdisciplinary meeting involved chemotherapy combined with simultaneous blockade of beta-adrenergic receptors, followed by bilateral simple mastectomy." | 5.62 | Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol. ( Gorski, M; Hodorowicz-Zaniewska, D; Kargol, J; Luczynska, E; Popiela, TJ; Rudnicki, W; Szpor, J; Wysocki, PJ, 2021) |
| "Angiosarcomas are rare malignant tumors of vascular origin that represent a genuine therapeutic challenge." | 5.43 | Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study. ( André, N; Banavali, SD; Chougule, A; Ghosh, J; Kavallaris, M; MacKenzie, KL; Meurer, M; Pasquier, E; Philip, DSJ; Rekhi, B; Street, J, 2016) |
| "The goal of this neoadjuvant window of opportunity study is to prospectively evaluate the activity of propranolol monotherapy in patients with cutaneous angiosarcoma." | 5.34 | PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study. ( Beijnen, JH; Haas, RL; Heinhuis, KM; Huitema, ADR; IJzerman, NS; Koenen, AM; Steeghs, N; van der Graaf, WTA; van Houdt, WJ, 2020) |
| " This study aimed to evaluate the clinical efficacy and adverse events (AEs) of anthracycline and propranolol combination in stage 3 HSA-affected dogs." | 1.91 | Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma. ( Fujii, Y; Goto, S; Iwasaki, R; Mori, T; Terauchi, M; Yoshikawa, R, 2023) |
| " The treatment agreed during the interdisciplinary meeting involved chemotherapy combined with simultaneous blockade of beta-adrenergic receptors, followed by bilateral simple mastectomy." | 1.62 | Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol. ( Gorski, M; Hodorowicz-Zaniewska, D; Kargol, J; Luczynska, E; Popiela, TJ; Rudnicki, W; Szpor, J; Wysocki, PJ, 2021) |
| "Angiosarcomas are rare malignant tumors of vascular origin that represent a genuine therapeutic challenge." | 1.43 | Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study. ( André, N; Banavali, SD; Chougule, A; Ghosh, J; Kavallaris, M; MacKenzie, KL; Meurer, M; Pasquier, E; Philip, DSJ; Rekhi, B; Street, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nyers, E | 1 |
| Perry, DM | 1 |
| De Jesús, G | 1 |
| Terauchi, M | 1 |
| Fujii, Y | 1 |
| Goto, S | 1 |
| Iwasaki, R | 1 |
| Yoshikawa, R | 1 |
| Mori, T | 1 |
| Heinhuis, KM | 1 |
| IJzerman, NS | 1 |
| Koenen, AM | 1 |
| van der Graaf, WTA | 1 |
| Haas, RL | 1 |
| Beijnen, JH | 1 |
| Huitema, ADR | 1 |
| van Houdt, WJ | 1 |
| Steeghs, N | 1 |
| Luczynska, E | 1 |
| Rudnicki, W | 1 |
| Kargol, J | 1 |
| Szpor, J | 1 |
| Hodorowicz-Zaniewska, D | 1 |
| Wysocki, PJ | 1 |
| Gorski, M | 1 |
| Popiela, TJ | 1 |
| Daguzé, J | 1 |
| Saint-Jean, M | 1 |
| Dréno, B | 1 |
| Stiles, JM | 1 |
| Amaya, C | 1 |
| Rains, S | 2 |
| Diaz, D | 1 |
| Pham, R | 1 |
| Battiste, J | 1 |
| Modiano, JF | 1 |
| Kokta, V | 1 |
| Boucheron, LE | 1 |
| Mitchell, DC | 1 |
| Bryan, BA | 2 |
| Chow, W | 1 |
| Amaya, CN | 1 |
| Chow, M | 1 |
| Dickerson, EB | 1 |
| Pasquier, E | 1 |
| André, N | 1 |
| Street, J | 1 |
| Chougule, A | 1 |
| Rekhi, B | 1 |
| Ghosh, J | 1 |
| Philip, DSJ | 1 |
| Meurer, M | 1 |
| MacKenzie, KL | 1 |
| Kavallaris, M | 1 |
| Banavali, SD | 1 |
1 trial available for propranolol and Angiosarcoma
| Article | Year |
|---|---|
PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study.
Topics: Adrenergic beta-Antagonists; Hemangiosarcoma; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Loca | 2020 |
7 other studies available for propranolol and Angiosarcoma
| Article | Year |
|---|---|
Oral Propranolol Used as Adjunct Therapy in Cutaneous Angiosarcoma.
Topics: Combined Modality Therapy; Hemangiosarcoma; Humans; Propranolol; Skin Neoplasms | 2022 |
Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Dog Diseases; Dogs; Endothelial Cells; Hemangi | 2023 |
Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol.
Topics: Breast Neoplasms; Female; Hemangiosarcoma; Humans; Mastectomy; Neoadjuvant Therapy; Propranolol | 2021 |
Large nose angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hemangiosarcoma; Humans; Male; Mid | 2018 |
Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Movement | 2013 |
Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Face; Hem | 2015 |
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy | 2016 |